StockGlow

Amarantus BioScience Holdings, Inc. (AMBS)

Develops blood tests and drug treatments for Alzheimer's, Parkinson's, and severe burns.

$0.00+0.00%Healthcare
Compare AMBS with
StockGlow Score
67
Leaning Bullish
BearishBullish
1 year ago-66.7%

The outlook

AMBS is trading at $0.0001, positioned well above its 50- and 200-day moving averages. The stock sits in the lower third of its 52-week range. Analyst coverage appears limited for this microcap stock.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range31% of the way from its 52-week low to high
Market cap
$63,040
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—

Similar stocks

ELTPElite Pharmaceuticals, Inc.$0.38-1.32%TOMDFTodos Medical Ltd.$0.00+0.00%BIEIPremier Biomedical, Inc.$0.00+10.00%PLPLPlandaí Biotechnology, Inc.$0.00+900.00%EXMTAnything Technologies Media, Inc.$0.00+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy